For PAH Treatment, Mylan Launches Tadalafil Tablets, 1st Generic...
2018年8月22日 · Mylan Announces U.S. Launch of 20 mg Tadalafil Tablets, 1st Generic of Adcirca for PAH Treatment. by Iqra Mumal, MSc August 22, 2018. Mylan recently introduced a …
Pulmonary Arterial Pressure Above 30 mmHg Linked to Increased...
by Iqra Mumal, MSc July 8, 2019. An estimated right ventricular systolic pressure (eRVSP) — a measure of the pressure inside the artery that supplies blood to the lungs (pulmonary artery) …
FDA approves sotatercept, now Winrevair, to treat PAH in adults
2024年3月27日 · The now-approved treatment is expected to be available for dispensing by select U.S. specialty pharmacies by the end of April, according to Merck, which has owned the rights …
Pulmonary Venous Hypertension (PVH)
2021年6月29日 · The symptoms of PVH are similar to those of other types of PH. Patients may experience shortness of breath, tiredness, chest pain, and fainting during normal activity, but …
Tyvaso DPI Earns FDA Priority Review Status - Pulmonary …
2021年6月18日 · Priority review shortens the FDA’s review period to eight months, down from the standard one year. United Therapeutics, developers of Tyvaso DPI and other treprostinil …
Flolan (Epoprostenol GM) - Pulmonary Hypertension News
2023年2月7日 · Flolan (epoprostenol GM), approved more than 25 years ago in the U.S., was the first therapy for pulmonary arterial hypertension (PAH). It is indicated as an into-the-vein …
Tyvaso Becomes 1st PH-ILD Treatment Approved in US
2021年4月1日 · The U.S. Food and Drug Administration (FDA) approved Tyvaso, developed by United Therapeutics, to improve exercise ability in PH-ILD patients, the company said. “The …
Uptravi for PH – Pulmonary Hypertension News
Uptravi (selexipag) is medication given orally or via intravenous infusion (into-the-vein, IV) to delay disease progression and reduce the risk of hospitalization in patients with pulmonary arterial …
Updated PAH Treatment Guidelines Released by CHEST
2019年2月13日 · The free guide, titled “ Therapy for Pulmonary Arterial Hypertension in Adults 2018: Update of the CHEST Guideline and Expert Panel Report, ” was published in the journal …
Tyvaso DPI Approved by the FDA for PAH and PH-ILD
2022年5月25日 · Tyvaso DPI is now the only dry powder inhaler approved by the FDA for use in PAH and PH-ILD, according to the therapy’s developer, United Therapeutics.The FDA had …